Some evidence also presented the potential of reduced GvHD in NSGW-NeoThy mice by administration of anti-human CD2 antibodies to remove GVHD-associated passenger thymocytes, but a more comprehensive study must be conducted to elucidate GvHD development in the model (39). The gene discussed is CD2; the disease is graft versus host disease.